Retrospective registry evaluating the PSA flare phenomenon with cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC).
Antoine Angelergues
No relevant relationships to disclose
Florence Mercier
Consultant or Advisory Role - Boston Scientific; Boston Scientific; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; GlaxoSmithKline; GlaxoSmithKline; Sanofi ; Sanofi
Aude Flechon
Honoraria - Sanofi
Aline Guillot
Consultant or Advisory Role - X; X
Sylvestre Le Moulec
No relevant relationships to disclose
Gwenaelle Gravis
Consultant or Advisory Role - Sanofi (U)
Philippe Beuzeboc
Honoraria - Sanofi ; Specific speeches
Christophe Massard
No relevant relationships to disclose
Karim Fizazi
Consultant or Advisory Role - Amgen; Amgen; Amgen; Astellas Pharma; AstraZeneca; Janssen Oncology; Janssen Oncology; Janssen Pharmaceutical ; Keocyt; Keocyt; Keocyt; Novartis; Sanofi ; Sanofi ; Sanofi
Thibault De La Motte Rouge
Consultant or Advisory Role - Sanofi ; Sanofi
Honoraria - Sanofi ; Sanofi
Research Funding - Astellas Pharma; Astellas Pharma; Millennium; Millennium
Reza-Thierry Elaidi
No relevant relationships to disclose
Stephane Oudard
Consultant or Advisory Role - Amgen; Amgen; Bayer; Bayer; Keocyt; Keocyt; Novartis; Novartis; Roche; Roche; Sanofi ; Sanofi
Honoraria - Amgen; Amgen; Bayer; Bayer; Keocyt; Keocyt; Novartis; Novartis; Pfizer; Pfizer; Roche; Roche; Sanofi ; Sanofi